Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Zong Chao Gou"'
Publikováno v:
Breast, Vol 60, Iss , Pp 247-254 (2021)
Background: Postmastectomy radiotherapy (PMRT), as an important regional treatment, improves the survival rate of patients with T3N0M0 breast cancers. However, the therapeutic effect of PMRT on T3N0M0 patients in different age groups is unclear. Meth
Externí odkaz:
https://doaj.org/article/bc03db731e134fd0961b2f4559a243b7
Publikováno v:
The Breast : Official Journal of the European Society of Mastology
Breast, Vol 60, Iss, Pp 247-254 (2021)
Breast, Vol 60, Iss, Pp 247-254 (2021)
Background Postmastectomy radiotherapy (PMRT), as an important regional treatment, improves the survival rate of patients with T3N0M0 breast cancers. However, the therapeutic effect of PMRT on T3N0M0 patients in different age groups is unclear. Metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01a98bc452cbcba35dc688e953b6a667
https://pubmed.ncbi.nlm.nih.gov/34808436
https://pubmed.ncbi.nlm.nih.gov/34808436
Autor:
Xiao-En Xu, Ding Ma, Zhi-Ming Shao, Li-Ping Ge, Wang Jiang, Zong-Chao Gou, Xi-Yu Liu, Yun-Song Yang, Yi-Zhou Jiang
Publikováno v:
Theranostics
Background: Taxanes are frontline chemotherapeutic drugs for patients with triple-negative breast cancer (TNBC); however, chemoresistance reduces their effectiveness. We hypothesized that the molecular profiling of tumor samples before and after neoa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5b4e76aa57d49e53ee7c627427b826e
https://doi.org/10.7150/thno.45207
https://doi.org/10.7150/thno.45207
Publikováno v:
Cancer Management and Research
Li-Ping Ge,1,2,* Xi-Yu Liu,1,2,* Yi Xiao,1,2 Zong-Chao Gou,1,2 Shen Zhao,1,2 Yi-Zhou Jiang,1,2 Gen-Hong Di1,2 1Department of Breast Surgery, Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China; 2Departmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4b886ef1737fd499f5306be27ae22b0
https://doi.org/10.2147/cmar.s169019
https://doi.org/10.2147/cmar.s169019
Publikováno v:
Cancer Management and Research
Zong-Chao Gou,1,2,* Xi-Yu Liu,1,2,* Yi Xiao,1,2 Shen Zhao,1,2 Yi-Zhou Jiang,1,2 Zhi-Ming Shao1–3 1Department of Breast Surgery, Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China; 2Department of Oncolo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::870f9ffa2a61a227ce23fcbf4713b3a2
https://doi.org/10.2147/cmar.s165291
https://doi.org/10.2147/cmar.s165291
Publikováno v:
Translational Cancer Research. 6:588-598
Breast cancer is the most frequently diagnosed cancer in Chinese women, and early-stage patients are significantly increasing. Surgery is the main treatment for early-stage breast cancer with the “minimally invasive procedures” concept. The modal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2572cf876ff9bb91b2092368429cdd72
https://doi.org/10.21037/tcr.2017.06.35
https://doi.org/10.21037/tcr.2017.06.35